NCT05291676View on ClinicalTrials.gov

Systems Investigation of Vaccine Responses in Aging and Frailty

PHASE2RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Influenza
Interventions
BIOLOGICAL

Fluzone

Fluzone High-Dose 0.7 ml intramuscular injection, standard as recommended by manufacturer

BIOLOGICAL

Fluad

Fluad Quadrivalent, MF59 adjuvanted 0.5 ml intramuscular injection, standard as recommended by manufacturer

Trial Locations (1)

06520

RECRUITING

Yale School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Yale University

OTHER